Novel dual PPARα/γ agonists protect against liver steatosis and improve insulin sensitivity while avoiding side effects

Critical nodes in signalling pathways: insights into insulin action

Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · see citing works

Type 2 diabetes: principles of pathogenesis and therapy

Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)61032-x · Cited by 2,662 · see citing works

What we talk about when we talk about fat

Rosen, E. D., & Spiegelman, B. M. (2014) · Cell · doi:10.1016/j.cell.2013.12.012 · Cited by 2,373 · see citing works

PPARγ signaling and metabolism: the good, the bad and the future

Ahmadian, M., Suh, J. M., Hah, N., Liddle, C., Atkins, A. R., Downes, M., & Evans, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3159 · Cited by 2,016 · see citing works

PPARs and the complex journey to obesity

Evans, R. M., Barish, G. D., & Wang, Y.-X. (2004) · Nature Medicine · doi:10.1038/nm1025 · Cited by 1,621 · see citing works

The Many Faces of PPARγ

Lehrke, M., & Lazar, M. A. (2005) · Cell · doi:10.1016/j.cell.2005.11.026 · Cited by 1,452 · see citing works

The GLUT4 Glucose Transporter

Huang, S., & Czech, M. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.03.006 · Cited by 1,399 · see citing works

Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions

Yamauchi, T., Nio, Y., Maki, T., Kobayashi, M., Takazawa, T., Iwabu, M., Okada-Iwabu, M., Kawamoto, S., Kubota, N., Kubota, T., et al. (2007) · Nature Medicine · doi:10.1038/nm1557 · Cited by 1,396 · see citing works

Characterization of the AMP-activated Protein Kinase Kinase from Rat Liver and Identification of Threonine 172 as the Major Site at Which It Phosphorylates AMP-activated Protein Kinase

Hawley, S. A., Davison, M., Woods, A., Davies, S. P., Beri, R. K., Carling, D., & Hardie, D. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27879 · Cited by 1,264 · see citing works

The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes

Perry, R. J., Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2014) · Nature · doi:10.1038/nature13478 · Cited by 1,136 · see citing works

Adipose-specific peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat and liver but not in muscle

He, W., Barak, Y., Hevener, A. L., Olson, P., Liao, D., Le, J., Nelson, M. C., Ong, E. S., Olefsky, J. M., & Evans, R. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536828100 · Cited by 978 · see citing works

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity

Okada-Iwabu, M., Yamauchi, T., Iwabu, M., Honma, T., Hamagami, K.-I., Matsuda, K., Yamaguchi, M., Tanabe, H., Kimura-Someya, T., Shirouzu, M., et al. (2013) · Nature · doi:10.1038/nature12656 · Cited by 757 · see citing works

Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD

Montagner, A., Polizzi, A., Fouché, E., Ducheix, S., Lippi, Y., Lasserre, F., Barquissau, V., Régnier, M., Lukowicz, C., Benhamed, F., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310798 · Cited by 746 · see citing works

Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice

Lin, Z., Tian, H., Lam, K. S. L., Lin, S., Hoo, R. C. L., Konishi, M., Itoh, N., Wang, Y., Bornstein, S. R., Xu, A., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.005 · Cited by 691 · see citing works

Fibroblast Growth Factor-21 Regulates PPARγ Activity and the Antidiabetic Actions of Thiazolidinediones

Dutchak, P. A., Katafuchi, T., Bookout, A. L., Choi, J. H., Yu, R. T., Mangelsdorf, D. J., & Kliewer, S. A. (2012) · Cell · doi:10.1016/j.cell.2011.11.062 · Cited by 537 · see citing works

Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes

Soccio, R. E., Chen, E. R., & Lazar, M. A. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.08.005 · Cited by 518 · see citing works

Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus

Ferguson, D., & Finck, B. N. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00507-z · Cited by 507 · see citing works

PPAR gamma 2 Prevents Lipotoxicity by Controlling Adipose Tissue Expandability and Peripheral Lipid Metabolism

Medina‐Gómez, G., Gray, S. L., Yetukuri, L., Shimomura, K., Virtue, S., Campbell, M., Curtis, R. K., Jimenez‐Liñan, M., Blount, M., Yeo, G. S. H., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030064 · Cited by 431 · see citing works

Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men

Petersen, K. F., Dufour, S., Feng, J., Befroy, D., Dziura, J., Man, C. D., Cobelli, C., & Shulman, G. I. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608537103 · Cited by 403 · see citing works

Diabetes mellitus and its complications in India

Ranjit Unnikrishnan, I., Anjana, R. M., & Mohan, V. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.53 · Cited by 403 · see citing works

Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus

Tahrani, A. A., Barnett, A. H., & Bailey, C. J. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.86 · Cited by 398 · see citing works

Thirty sweet years of GLUT4

Klip, A., McGraw, T. E., & James, D. E. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.008351 · Cited by 344 · see citing works

Dietary fructose in nonalcoholic fatty liver disease

Vos, M. B., & Lavine, J. E. (2013) · Hepatology · doi:10.1002/hep.26299 · Cited by 316 · see citing works

Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors

Francque, S., Szabo, G., Abdelmalek, M. F., Byrne, C. D., Cusi, K., Dufour, J.-F., Roden, M., Sacks, F., & Tacke, F. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00366-5 · Cited by 316 · see citing works

Genetic Liver-Specific AMPK Activation Protects against Diet-Induced Obesity and NAFLD

Garcia, D., Hellberg, K., Chaix, A., Wallace, M., Herzig, S., Badur, M. G., Lin, T. C., Shokhirev, M. N., Pinto, A. F. M., Ross, D. S., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.036 · Cited by 294 · see citing works

Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes

Choi, Y.-J., Shin, H.-S., Choi, H. S., Park, J.-W., Jo, I., Oh, E., Lee, K.-Y., Lee, B., Johnson, R. J., & Kang, D. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.98 · Cited by 286 · see citing works

Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues

LeBrasseur, N. K., Kelly, M., Tsao, T.-S., Farmer, S. R., Saha, A. K., Ruderman, N. B., & Tomas, E. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00453.2005 · Cited by 276 · see citing works

Adipocyte NCoR Knockout Decreases PPARγ Phosphorylation and Enhances PPARγ Activity and Insulin Sensitivity

Li, P., Fan, W., Xu, J., Lu, M. M., Yamamoto, H., Auwerx, J. H., Sears, D. D., Talukdar, S., Oh, D., Chen, A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.050 · Cited by 264 · see citing works

PPARγ activation in adipocytes is sufficient for systemic insulin sensitization

Sugii, S., Olson, P., Sears, D. D., Saberi, M., Atkins, A. R., Barish, G. D., Hong, S.-H., Castro, G. L., Yin, Y.-Q., Nelson, M. C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912487106 · Cited by 255 · see citing works

The role of PPARs in atherosclerosis

Duval, C., Chinetti, G., Trottein, F., Fruchart, J., & Staels, B. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02385-7 · Cited by 246 · see citing works

The lipid sensor GPR120 promotes brown fat activation and FGF21 release from adipocytes

Quesada‐López, T., Cereijo, R., Turatsinze, J., Planavila, A., Cairó, M., Gavaldà‐Navarro, A., Peyrou, M., Moure, R., Iglesias, R., Giralt, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms13479 · Cited by 231 · see citing works

Bridging the GAP between insulin signaling and GLUT4 translocation

Watson, R. T., & Pessin, J. E. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.02.007 · Cited by 219 · see citing works

Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4

Kim, J. K., Zisman, A., Fillmore, J. J., Peroni, O. D., Kotani, K., Perret, P., Zong, H., Dong, J., Kahn, C. R., Kahn, B. B., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10294 · Cited by 202 · see citing works

C/EBPα and the Corepressors CtBP1 and CtBP2 Regulate Repression of Select Visceral White Adipose Genes during Induction of the Brown Phenotype in White Adipocytes by Peroxisome Proliferator-Activated Receptor γ Agonists

Vernochet, C., Peres, S. B., Davis, K. E., McDonald, M. E., Qiang, L., Wang, H., Scherer, P. E., & Farmer, S. R. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01899-08 · Cited by 199 · see citing works

Metformin Ameliorates Hepatic Steatosis and Inflammation without Altering Adipose Phenotype in Diet-Induced Obesity

Woo, S., Xu, H., Li, H., Zhao, Y., Hu, X., Zhao, J., Guo, X., Guo, T., Botchlett, R. E., Qi, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091111 · Cited by 194 · see citing works

Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease

Negi, C. K., Babica, P., Bajard, L., Vašků, J. B., & Tarantino, G. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154925 · Cited by 193 · see citing works

What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?

Finelli, C. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i6.802 · Cited by 184 · see citing works

Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function

Spruss, A., Kanuri, G., Stahl, C., Bischoff, S. C., & Bergheim, I. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.75 · Cited by 168 · see citing works

Adiponectin: a relevant player in PPARγ-agonist-mediated improvements in hepatic insulin sensitivity?

Bouskila, M., Pajvani, U. B., & Scherer, P. E. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802908 · Cited by 149 · see citing works

Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity

Régnier, M., Polizzi, A., Smati, S., Lukowicz, C., Fougerat, A., Lippi, Y., Fouché, E., Lasserre, F., Naylies, C., Bétoulières, C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-63579-3 · Cited by 141 · see citing works

Liver Enzyme Monitoring in Patients Treated With Troglitazone

Graham, D. J. (2001) · JAMA · doi:10.1001/jama.286.7.831 · Cited by 138 · see citing works

The Therapeutic Potential of Nuclear Receptor Modulators for Treatment of Metabolic Disorders: PPARγ, RORs, and Rev-erbs

Marciano, D. P., Chang, M. R., Corzo, C. A., Goswami, D., Lam, V. Q., Pascal, B. D., & Griffin, P. R. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.12.009 · Cited by 124 · see citing works

Browning of White Adipose Tissue with Roscovitine Induces a Distinct Population of UCP1 + Adipocytes

Wang, H., Liu, L., Lin, J. Z., Aprahamian, T. R., & Farmer, S. R. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.10.005 · Cited by 124 · see citing works

Transcriptional regulation of the GLUT4 gene: from PPAR-γ and FOXO1 to FFA and inflammation

Armoni, M., Harel, C., & Karnieli, E. (2007) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2007.02.001 · Cited by 122 · see citing works

Ligands for the Nuclear Peroxisome Proliferator-Activated Receptor Gamma

Sauer, S. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.06.010 · Cited by 118 · see citing works

The Size of Large Adipose Cells Is a Predictor of Insulin Resistance in First‐Degree Relatives of Type 2 Diabetic Patients

Yang, J., Eliasson, B., Smith, U., Cushman, S. W., & Sherman, A. (2012) · Obesity · doi:10.1038/oby.2011.371 · Cited by 111 · see citing works

TAZ Is a Negative Regulator of PPARγ Activity in Adipocytes and TAZ Deletion Improves Insulin Sensitivity and Glucose Tolerance

Ouarrat, D. E., Isaac, R., Lee, Y. S., Oh, D. Y., Wollam, J., Lackey, D. E., Riopel, M., Bandyopadhyay, G. K., Seo, J. B., Sampath-Kumar, R., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.10.003 · Cited by 104 · see citing works

Role of PPAR in Hepatic Carbohydrate Metabolism

Peeters, A., & Baes, M. I. (2010) · PPAR Research · doi:10.1155/2010/572405 · Cited by 102 · see citing works

PPARγ Antagonist Gleevec Improves Insulin Sensitivity and Promotes the Browning of White Adipose Tissue

Choi, S., Kim, E. S., Jung, J., Marciano, D. P., Jo, A., Koo, J. Y., Choi, S. Y., Yang, Y. R., Jang, H., Kim, E., et al. (2016) · Diabetes · doi:10.2337/db15-1382 · Cited by 100 · see citing works

The GPR120 agonist TUG‐891 promotes metabolic health by stimulating mitochondrial respiration in brown fat

Schilperoort, M., van Dam, A. D., Hoeke, G., Shabalina, I. G., Okolo, A., Hanyaloglu, A. C., Dib, L. H., Mol, I. M., Caengprasath, N., Chan, Y., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708047 · Cited by 100 · see citing works

SIRT6 Promotes Hepatic Beta-Oxidation via Activation of PPARα

Naiman, S., Huynh, F. K., Gil, R., Glick, Y., Shahar, Y., Touitou, N., Nahum, L., Avivi, M. Y., Roichman, A., Kanfi, Y., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.067 · Cited by 100 · see citing works

PPARα-Deficient ob/ob Obese Mice Become More Obese and Manifest Severe Hepatic Steatosis Due to Decreased Fatty Acid Oxidation

Gao, Q., Jia, Y., Yang, G., Zhang, X., Boddu, P. C., Petersen, B. E., Narsingam, S., Zhu, Y.-J., Thimmapaya, B., Kanwar, Y. S., et al. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.01.018 · Cited by 91 · see citing works

PPARs: Nuclear Receptors Controlled by, and Controlling, Nutrient Handling through Nuclear and Cytosolic Signaling

Moreno, M., Lombardi, A., Silvestri, E., Senese, R., Cioffi, F., Goglia, F., Lanni, A., & de Lange, P. (2010) · PPAR Research · doi:10.1155/2010/435689 · Cited by 74 · see citing works

Diabetes drugs for nonalcoholic fatty liver disease: a systematic review

Blazina, I., & Selph, S. (2019) · Systematic Reviews · doi:10.1186/s13643-019-1200-8 · Cited by 74 · see citing works

PPAR α in Obesity: Sex Difference and Estrogen Involvement

Yoon, M. (2010) · PPAR Research · doi:10.1155/2010/584296 · Cited by 71 · see citing works

Fenofibrate regulates obesity and lipid metabolism with sexual dimorphism

Yoon, M., Jeong, S., Nicol, C. J. B., Lee, H., Han, M., Kim, J.-J., Seo, Y.-J., Ryu, C., & Oh, G. T. (2002) · Experimental & Molecular Medicine · doi:10.1038/emm.2002.67 · Cited by 68 · see citing works

Brown adipose tissue transplantation as a novel alternative to obesity treatment: a systematic review

Payab, M., Abedi, M., Heravani, N. F., Hadavandkhani, M., Arabi, M., Tayanloo-Beik, A., Hosseini, M. S., Gerami, H., Khatami, F., Larijani, B. A., et al. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0616-5 · Cited by 68 · see citing works

Pongamol from Pongamia pinnata stimulates glucose uptake by increasing surface GLUT4 level in skeletal muscle cells

Tamrakar, A. K., Jaiswal, N., Yadav, P. P., Maurya, R., & Srivastava, A. K. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.03.023 · Cited by 65 · see citing works

The Role of AMPK in Neuromuscular Biology and Disease

Dial, A. G., Ng, S. Y., Manta, A., & Ljubicic, V. (2018) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2018.02.010 · Cited by 43 · see citing works

LT175 Is a Novel PPARα/γ Ligand with Potent Insulin-sensitizing Effects and Reduced Adipogenic Properties

Gilardi, F., Giudici, M., Mitro, N., Maschi, O., Guerrini, U., Rando, G., Maggi, A. C., Cermenati, G., Laghezza, A., Loiodice, F., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.506394 · Cited by 39 · see citing works

Oxymatrine ameliorates non-alcoholic fatty liver disease in rats through peroxisome proliferator-activated receptor-α activation

Shi, L., Shi, L., Zhang, H., Hu, Z., Wang, C., ZHANG, D., & Song, G. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1512 · Cited by 32 · see citing works

α-Amyrin attenuates high fructose diet-induced metabolic syndrome in rats

Prabhakar, P., Reeta, K. H., Maulik, S. K., Dinda, A. K., & Gupta, Y. K. (2016) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2016-0088 · Cited by 28 · see citing works

C333H, a novel PPARalpha/gamma dual agonist, has beneficial effects on insulin resistance and lipid metabolism1

Xu, C., Wang, L., Liu, H., Zhou, X.-B., Cao, Y.-L., & Li, S. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00263.x · Cited by 26 · see citing works

Evidence of differing genotypic effects of PPARα in women and men

Khan, Q. H., Pontefract, D. E., Iyengar, S., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.014407 · Cited by 11 · see citing works

A Novel Partial PPARγ Agonist Has Weaker Lipogenic Effect in Adipocytes and Stimulates GLUT4 Translocation in Skeletal Muscle Cells via AMPK-Dependent Signaling

Bhavimani, G., Tamrakar, A. K., Mandal, S. P., Kumar, B. R. P., Sharma, A., & Manjula, S. N. (2021) · Pharmacology · doi:10.1159/000519331 · Cited by 3 · see citing works

Molecular Targets of 20-Hydroxyecdysone in Mammals, Mechanism of Action: Is It a Calorie Restriction Mimetic and Anti-Aging Compound?

Zádor, E. (2025) · Cells · doi:10.3390/cells14060431 · Cited by 9 · see citing works

Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats

Ding, S.-Y., Shen, Z., Chen, Y.-T., Sun, S., Liu, Q., & Xie, M. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00090.x · Cited by 67 · see citing works

Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats

Shi-yingDING, Zhu-fangSHEN, Yue-tengCHEN, et al. (2005) · 中国药理学报：英文版

Obesity and insulin resistance in humans: A dose-response study

Bonadonna, R. C., Leif, G., Kraemer, N., Ferrannini, E., Prato, S. D., & DeFronzo, R. A. (1990) · Metabolism · doi:10.1016/0026-0495(90)90002-t · Cited by 355 · see citing works

Insulin resistance in the conscious spontaneously hypertensive rat: Euglycemic hyperinsulinemic clamp study

Hulman, S., Falkner, B. E., & Freyvogel, N. (1993) · Metabolism · doi:10.1016/0026-0495(93)90165-k · Cited by 72 · see citing works

[Effect of short-term experimental hyperinsulinemia on insulin binding and glucose oxidation in adipocytes].

Kang, Y. (1993) · PubMed